vs
Origin Bancorp, Inc.（OBK）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Origin Bancorp, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.5倍（$104.0M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 26.6%，领先357.4%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 3.9%）
Origin Bancorp旗下的南方银行是一家社区发展金融机构，总部位于阿肯色州阿卡德尔菲亚。该机构成立于1986年，最初名为南方开发银行公司，常被简称为“南方”，专注服务社区发展相关金融需求。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
OBK vs RIGL — 直观对比
营收规模更大
OBK
是对方的1.5倍
$69.8M
净利率更高
RIGL
高出357.4%
26.6%
两年增速更快
RIGL
近两年复合增速
3.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $104.0M | $69.8M |
| 净利润 | $27.7M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 26.6% | 384.0% |
| 营收同比 | — | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $0.89 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OBKRIGL
| Q1 26 | $104.0M | — | ||
| Q4 25 | $103.4M | $69.8M | ||
| Q3 25 | $109.8M | $69.5M | ||
| Q2 25 | $83.5M | $101.7M | ||
| Q1 25 | $94.1M | $53.3M | ||
| Q4 24 | $78.3M | $57.6M | ||
| Q3 24 | $90.8M | $55.3M | ||
| Q2 24 | $96.4M | $36.8M |
净利润OBKRIGL
| Q1 26 | $27.7M | — | ||
| Q4 25 | $29.5M | $268.1M | ||
| Q3 25 | $8.6M | $27.9M | ||
| Q2 25 | $14.6M | $59.6M | ||
| Q1 25 | $22.4M | $11.4M | ||
| Q4 24 | $14.3M | $14.3M | ||
| Q3 24 | $18.6M | $12.4M | ||
| Q2 24 | $21.0M | $-1.0M |
毛利率OBKRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% |
营业利润率OBKRIGL
| Q1 26 | — | — | ||
| Q4 25 | 36.2% | 33.2% | ||
| Q3 25 | 10.0% | 40.9% | ||
| Q2 25 | 22.3% | 60.1% | ||
| Q1 25 | 30.4% | 23.9% | ||
| Q4 24 | 23.0% | 28.9% | ||
| Q3 24 | 26.1% | 25.4% | ||
| Q2 24 | 27.7% | 1.2% |
净利率OBKRIGL
| Q1 26 | 26.6% | — | ||
| Q4 25 | 28.5% | 384.0% | ||
| Q3 25 | 7.9% | 40.2% | ||
| Q2 25 | 17.5% | 58.6% | ||
| Q1 25 | 23.8% | 21.5% | ||
| Q4 24 | 18.2% | 24.9% | ||
| Q3 24 | 20.5% | 22.5% | ||
| Q2 24 | 21.8% | -2.8% |
每股收益（稀释后）OBKRIGL
| Q1 26 | $0.89 | — | ||
| Q4 25 | $0.95 | $14.11 | ||
| Q3 25 | $0.27 | $1.46 | ||
| Q2 25 | $0.47 | $3.28 | ||
| Q1 25 | $0.71 | $0.63 | ||
| Q4 24 | $0.45 | $0.82 | ||
| Q3 24 | $0.60 | $0.70 | ||
| Q2 24 | $0.67 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $1.3B | $391.5M |
| 总资产 | $10.2B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资OBKRIGL
| Q1 26 | — | — | ||
| Q4 25 | $424.2M | $155.0M | ||
| Q3 25 | $626.9M | $137.1M | ||
| Q2 25 | $334.1M | $108.4M | ||
| Q1 25 | $486.2M | $77.1M | ||
| Q4 24 | $470.2M | $77.3M | ||
| Q3 24 | $321.2M | $61.1M | ||
| Q2 24 | $288.1M | $49.1M |
总债务OBKRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M |
股东权益OBKRIGL
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.2B | $391.5M | ||
| Q3 25 | $1.2B | $117.6M | ||
| Q2 25 | $1.2B | $81.9M | ||
| Q1 25 | $1.2B | $18.6M | ||
| Q4 24 | $1.1B | $3.3M | ||
| Q3 24 | $1.1B | $-14.6M | ||
| Q2 24 | $1.1B | $-29.9M |
总资产OBKRIGL
| Q1 26 | $10.2B | — | ||
| Q4 25 | $9.7B | $513.6M | ||
| Q3 25 | $9.8B | $242.5M | ||
| Q2 25 | $9.7B | $206.7M | ||
| Q1 25 | $9.8B | $176.0M | ||
| Q4 24 | $9.7B | $164.0M | ||
| Q3 24 | $10.0B | $139.4M | ||
| Q2 24 | $9.9B | $128.4M |
负债/权益比OBKRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流OBKRIGL
| Q1 26 | — | — | ||
| Q4 25 | $158.9M | $22.0M | ||
| Q3 25 | $59.3M | $24.0M | ||
| Q2 25 | $20.6M | $30.5M | ||
| Q1 25 | $35.6M | $-893.0K | ||
| Q4 24 | $108.5M | $14.5M | ||
| Q3 24 | $39.6M | $21.7M | ||
| Q2 24 | $11.9M | $302.0K |
自由现金流OBKRIGL
| Q1 26 | — | — | ||
| Q4 25 | $151.1M | — | ||
| Q3 25 | $56.8M | — | ||
| Q2 25 | $19.6M | — | ||
| Q1 25 | $34.8M | — | ||
| Q4 24 | $86.4M | — | ||
| Q3 24 | $32.2M | — | ||
| Q2 24 | $6.5M | — |
自由现金流率OBKRIGL
| Q1 26 | — | — | ||
| Q4 25 | 146.0% | — | ||
| Q3 25 | 51.7% | — | ||
| Q2 25 | 23.5% | — | ||
| Q1 25 | 37.0% | — | ||
| Q4 24 | 110.3% | — | ||
| Q3 24 | 35.5% | — | ||
| Q2 24 | 6.8% | — |
资本支出强度OBKRIGL
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | — | ||
| Q3 25 | 2.3% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 28.1% | — | ||
| Q3 24 | 8.1% | — | ||
| Q2 24 | 5.6% | — |
现金转化率OBKRIGL
| Q1 26 | — | — | ||
| Q4 25 | 5.38× | 0.08× | ||
| Q3 25 | 6.88× | 0.86× | ||
| Q2 25 | 1.41× | 0.51× | ||
| Q1 25 | 1.59× | -0.08× | ||
| Q4 24 | 7.60× | 1.01× | ||
| Q3 24 | 2.13× | 1.75× | ||
| Q2 24 | 0.57× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OBK
| Net Interest Income | $87.2M | 84% |
| Noninterest Income | $16.8M | 16% |
RIGL
暂无分部数据
